Feed/Investors/Pro Benefis Familiae

Pro Benefis Familiae

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-09-22

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$90M

across 1 round

LATEST ROUND

Funding round · $90M · 2026-09-22

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
HighLife HighLife develops a transcatheter system for replacing the mitral valve in patients with heart valve disease.	Funding round Verified against 4 of 9 sources	$90M	2026-09-22	[ PART ]